Discovery Pipeline

Apr 22, 2014
By BioPharm International Editors
Research reveals that proteins involved in autism interact with many more partners than previously known.
Oct 01, 2013
BioPharm International
By BioPharm International Editors
The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.
Apr 02, 2013
BioPharm International
By BioPharm International Editors
A conversation with Armand Keating, the Epstein Chair in Cell Therapy and Transplantation at the University of Toronto prior to his presentation at Bio 2013
Dec 01, 2012
BioPharm International
By BioPharm International Editors
Recent research examines the sequence of events underlying cellular reprogramming, which may aid in better control of the production of induced pluripotent stem cells.
Nov 01, 2012
BioPharm International
By BioPharm International Editors
Creating an effective nucleic acid-based vaccine requires protecting the fragile nucleic acid from degradation, effective transfection of the targeted cells, and producing high enough levels of antigen to evoke a robust immune response.
Oct 01, 2012
BioPharm International
By BioPharm International Editors
Recently published research demonstrates how nanoparticles can be used to overcome hurdles in localized drug delivery.
Sep 01, 2012
BioPharm International
By BioPharm International Editors
NIH has awarded ten laboratories two-year grants to develop tissue chip technology, with part of the funding coming from the recently established National Center for Advancing Translational Science.
Dec 05, 2011
By BioPharm International Editors
BioPharm International interviews Trevor Hallam, chief scientific officer at Sutro Biopharma. Posted Dec. 2011.
native1_300x100
lorem ipsum